Kefir for Anti-Inflammatory

Research suggests that kefir possesses meaningful anti-inflammatory potential, with evidence spanning animal studies, cell culture experiments, and a small number of human trials pointing in a broadly consistent direction. A 2024 systematic review of 23 animal studies found that kefir reduced pro-inflammatory markers and helped balance immune responses, while earlier animal work identified specific components of kefir — including its polysaccharides and a recently isolated glycopeptide — as likely contributors to these effects; a 2025 randomized controlled trial in female athletes also observed increases in gut bacteria associated with anti-inflammatory activity following kefir consumption. Studies indicate that these effects may operate through several pathways, including suppression of the TLR4/NF-κB inflammatory signaling pathway, strengthening of the gut's barrier function, and shifts in microbiome composition toward short-chain fatty acid-producing species. However, a consistent limitation across the literature is that the majority of evidence comes from animal models and laboratory cell cultures rather than well-controlled human clinical trials, and two reviews described as neutral in direction caution that promising findings from non-human studies do not always translate to people, meaning the overall picture — while encouraging — remains preliminary for human anti-inflammatory applications.